中国民康医学
中國民康醫學
중국민강의학
MEDICAL JOURNAL OF CHINSEE PEOPLE HEALTH
2015年
12期
17-18
,共2页
赵良虎%刘典锋%黄金%陈志强%杨晓娜
趙良虎%劉典鋒%黃金%陳誌彊%楊曉娜
조량호%류전봉%황금%진지강%양효나
骨性关节炎%Lequesne 指数评分%玻璃酸钠%糖皮质激素
骨性關節炎%Lequesne 指數評分%玻璃痠鈉%糖皮質激素
골성관절염%Lequesne 지수평분%파리산납%당피질격소
Osteoarthritis%Lequesne index score%Sodium hyaluronate%Glucocorticoids
目的::通过 Lequesne 指数评分,比较早期膝关节骨性关节炎(OA)患者膝关节腔内分别注射透明质酸钠与糖皮质激素复方倍他米松的治疗效果[1]。方法:100例膝骨关节炎患者随机平均分为玻璃酸钠组与激素组,每组各50例。临床评估即 Lequesne 指数评分,评估是分别在第1、3、6个月评测。结果:在第1个月时,两组患者之间 Lequesne 指数评分均明显降低,与治疗前比较具有统计学意义;第3个月开始两组患者评分持续降低,但透明质酸钠组患者的 Lequesne 评分显著低于激素组;第6个月时,两组患者的 Lequesne 评分有回升趋势,数据显示两组中玻璃酸钠组评分回升显著慢于激素组,玻璃酸钠组患者的治疗后效果更为持久。结论:早期 OA 患者关节腔注射透明质酸与激素治疗可明显降低膝关节的 Lequesne 指数评分,但关节腔内注射玻璃酸钠效果更佳。
目的::通過 Lequesne 指數評分,比較早期膝關節骨性關節炎(OA)患者膝關節腔內分彆註射透明質痠鈉與糖皮質激素複方倍他米鬆的治療效果[1]。方法:100例膝骨關節炎患者隨機平均分為玻璃痠鈉組與激素組,每組各50例。臨床評估即 Lequesne 指數評分,評估是分彆在第1、3、6箇月評測。結果:在第1箇月時,兩組患者之間 Lequesne 指數評分均明顯降低,與治療前比較具有統計學意義;第3箇月開始兩組患者評分持續降低,但透明質痠鈉組患者的 Lequesne 評分顯著低于激素組;第6箇月時,兩組患者的 Lequesne 評分有迴升趨勢,數據顯示兩組中玻璃痠鈉組評分迴升顯著慢于激素組,玻璃痠鈉組患者的治療後效果更為持久。結論:早期 OA 患者關節腔註射透明質痠與激素治療可明顯降低膝關節的 Lequesne 指數評分,但關節腔內註射玻璃痠鈉效果更佳。
목적::통과 Lequesne 지수평분,비교조기슬관절골성관절염(OA)환자슬관절강내분별주사투명질산납여당피질격소복방배타미송적치료효과[1]。방법:100례슬골관절염환자수궤평균분위파리산납조여격소조,매조각50례。림상평고즉 Lequesne 지수평분,평고시분별재제1、3、6개월평측。결과:재제1개월시,량조환자지간 Lequesne 지수평분균명현강저,여치료전비교구유통계학의의;제3개월개시량조환자평분지속강저,단투명질산납조환자적 Lequesne 평분현저저우격소조;제6개월시,량조환자적 Lequesne 평분유회승추세,수거현시량조중파리산납조평분회승현저만우격소조,파리산납조환자적치료후효과경위지구。결론:조기 OA 환자관절강주사투명질산여격소치료가명현강저슬관절적 Lequesne 지수평분,단관절강내주사파리산납효과경가。
Objective: To compare clinical effects of sodium hyaluronate and glucocorticoid in treatment of early knee osteoar-thritis (OA) though Lequesne index score[1] . Methods: 100 patients with osteoarthritis were randomly divided into sodium hyalur-onate group and glucocorticoid group. The clinical assessments (Lequesne index score) were done at 1, 3, and 6 months. Results: At the first month, the Lequesne index scores of the two groups were significantly reduced, and the differences before and after the treat-ment were statistically significant. At the third month, the Lequesne index scores of the two groups continued to decrease; however, the Lequesne index score of sodium hyaluronate group was significantly lower than that of glucocorticoid group. At the sixth month, the two groups showed a rebounding trend of the Lequesne index score, and the data showed that the sodium hyaluronate group score signifi-cantly rebounded slower than that of glucocorticoid group, indicating the therapeutic effect of sodium hyaluronate group was more dura-ble than glucocorticoid group. Conclusions: For the Patients with early OA, sodium hyaluronate and glucocorticoid both can signifi-cantly reduce the Lequesne index score, but the intra-articular injection of sodium hyaluronate has a better therapeutic effect.